IL10 and cardiac hypertrophy: This hypothesis was supported by the following evidences: (1) Using TACE inhibitor TAPI-1 to increase tmTNF-α expression in WT mice significantly improved TAC-induced cardiac hypertrophy, decreased transcription of pro-inflammatory cytokines, and enhanced IL-10 mRNA expression.